Berry Compound Pterostilbene Reduces Muscle Fat in Cell Study

Study Identifies Berry Compound That Reduces Muscle Cell Fat

A research team led by Associate Professor Takakazu Mitani at Shinshu University has identified pterostilbene, a compound found in blueberries, grapes, and other berries, as effective in reducing fat buildup in cultured mouse skeletal muscle cells.

The study, published in Food Bioscience, screened various food-derived phytochemicals and found that pterostilbene most strongly suppressed abnormal intracellular lipid accumulation while allowing normal muscle cell growth and differentiation.

How Pterostilbene Works in Muscle Cells

The researchers found that pterostilbene does not block fatty acids from entering muscle cells. Instead, it increases the release of extracellular glycerol, which is a marker of fat breakdown, and boosts the expression of genes involved in fatty acid oxidation.

Further analysis showed that pterostilbene enhances the activity of peroxisome proliferator-activated receptor delta (PPARδ), a protein that regulates fat metabolism. Unlike most drugs that directly bind to PPARδ, pterostilbene prevents its degradation, increasing the amount of PPARδ protein available in the cell.

Evidence Comes From Cultured Mouse Muscle Cells

The findings are based on experiments using C2C12 mouse skeletal muscle cells grown in the lab. The effects of pterostilbene were observed at the cellular level and have not yet been tested in live animals or humans.

The study does not provide evidence for clinical efficacy or safety in people, and further research is needed to determine whether these results translate to real-world dietary or therapeutic use.

Implications for Metabolic Health and Future Research

Ectopic fat accumulation in skeletal muscle is linked to insulin resistance and metabolic disorders, making it a target for preventive strategies. The study suggests that pterostilbene and similar compounds could be explored as dietary interventions to support muscle fat metabolism.

The researchers note that there are currently no approved treatments specifically for myosteatosis (muscle fat accumulation), and their findings provide a framework for developing functional foods or supplements. However, in vivo studies are needed to confirm efficacy, safety, and target selectivity before practical recommendations can be made.

Limitations and Next Steps

The research was limited to cell culture models, so the effects of pterostilbene in humans remain unknown. The molecular mechanisms observed may not fully predict outcomes in living organisms.

Rigorous animal and human studies will be required to evaluate the safety and effectiveness of pterostilbene for metabolic health applications.